## **Core Concept**
Mixed Connective Tissue Disease (MCTD) is an autoimmune disorder that combines features of lupus, scleroderma, and rheumatoid arthritis. It is characterized by the presence of specific autoantibodies. The diagnosis of MCTD is primarily based on clinical manifestations and the detection of certain autoantibodies.

## **Why the Correct Answer is Right**
The correct answer, **Anti-U1 RNP**, is diagnostic of MCTD because these antibodies are highly specific for the disease. Anti-U1 RNP antibodies target the U1 small nuclear ribonucleoprotein complex and are found in nearly all patients with MCTD. High titers of anti-U1 RNP antibodies are often associated with MCTD and are considered a hallmark of the disease.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **Anti-dsDNA** antibodies are specific for Systemic Lupus Erythematosus (SLE), they can sometimes be present in MCTD but are not diagnostic of it.
- **Option B:** **Anti-Scl-70** (also known as anti-topoisomerase I) is more commonly associated with diffuse Systemic Sclerosis (scleroderma) and is not specific for MCTD.
- **Option D:** **Anti-Jo-1** antibodies are primarily found in patients with inflammatory myopathies (like polymyositis and dermatomyositis) and are not diagnostic of MCTD.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that while anti-U1 RNP antibodies are highly specific for MCTD, the disease itself presents with a mix of clinical features seen in lupus, scleroderma, and rheumatoid arthritis. Patients often have high titers of anti-U1 RNP antibodies and typically respond well to corticosteroids.

## **Correct Answer:** . Anti-U1 RNP